Cargando…

Alleviative effect of Ruellia tuberosa L. on NAFLD and hepatic lipid accumulation via modulating hepatic de novo lipogenesis in high‐fat diet plus streptozotocin‐induced diabetic rats

Ruellia tuberosa L. (RTL) exhibits phytochemical activities and has been used as a folk medicine for curing diabetes mellitus in East Asia for decades. This study investigated the effect of RTL aqueous and ethanolic extracts on nonalcoholic fatty liver disease (NAFLD) and hepatic lipid accumulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Da‐Wei, Lo, Yangming Martin, Chang, Wen‐Chang, Lin, Chia‐Yu, Chen, Jou‐An, Wu, James Swi‐Bea, Huang, Wen‐Chung, Shen, Szu‐Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590278/ https://www.ncbi.nlm.nih.gov/pubmed/33133572 http://dx.doi.org/10.1002/fsn3.1868

Ejemplares similares

Protective effect of Ruellia tuberosa L. extracts against abnormal expression of hepatic detoxification enzymes in diabetic rats
por: Chang, Wen-Chang, et al.
Publicado: (2018)

Effect of Ruellia tuberosa L. on aorta endothelial damage‐associated factors in high‐fat diet and streptozotocin‐induced type 2 diabetic rats
por: Ko, Chih‐Yuan, et al.
Publicado: (2019)

Identification of Bioactive Components from Ruellia tuberosa L. on Improving Glucose Uptake in TNF-α-Induced Insulin-Resistant Mouse FL83B Hepatocytes
por: Xu, Jian-Hua, et al.
Publicado: (2020)

Ameliorative effect of Ruellia tuberosa L. on hyperglycemia in type 2 diabetes mellitus and glucose uptake in mouse C2C12 myoblasts
por: Ko, Chih‐Yuan, et al.
Publicado: (2018)

Alleviative Effect of Ruellia tuberosa L. on Insulin Resistance and Abnormal Lipid Accumulation in TNF-α-Treated FL83B Mouse Hepatocytes
por: Chen, Hong-Jie, et al.
Publicado: (2021)

Histopathological Profiles of Rats (Rattus norvegicus) Induced with Streptozotocin and Treated with Aqueous Root Extracts of Ruellia tuberosa L.
por: Safitri, Anna, et al.
Publicado: (2021)

Alpha‐lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats
por: Ko, Chih‐Yuan, et al.
Publicado: (2021)

Ruellia tuberosa L. Extract Improves Histopathology and Lowers Malondialdehyde Levels and TNF Alpha Expression in the Kidney of Streptozotocin-Induced Diabetic Rats
por: Roosdiana, Anna, et al.
Publicado: (2020)

Antidiabetic Activity of Ruellia tuberosa L., Role of α-Amylase Inhibitor: In Silico, In Vitro, and In Vivo Approaches
por: Ratna Wulan, Dyah, et al.
Publicado: (2015)

Alleviative Effect of Alpha-Lipoic Acid on Cognitive Impairment in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats
por: Ko, Chih-Yuan, et al.
Publicado: (2021)

Microencapsulation of Ruellia tuberosa L. Aqueous Root Extracts Using Chitosan-Sodium Tripolyphosphate and Their In Vitro Biological Activities
por: Safitri, Anna, et al.
Publicado: (2022)

Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis
por: Kang, Hyena, et al.
Publicado: (2022)

Alleviative effects of α‐lipoic acid on muscle atrophy via the modulation of TNF‐α/JNK and PI3K/AKT pathways in high‐fat diet and streptozotocin‐induced type 2 diabetic rats
por: Ko, Chih‐Yuan, et al.
Publicado: (2023)

Molecular modeling of Ruellia tuberosa L compounds as a-amylase inhibitor: an in silico comparation between human and rat enzyme model
por: Wulan, Dyah Ratna, et al.
Publicado: (2014)

A simple optical pH sensor based on pectin and Ruellia tuberosa L-derived anthocyanin for fish freshness monitoring
por: Nazaruddin, Nazaruddin, et al.
Publicado: (2021)

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis
por: Valtolina, Chiara, et al.
Publicado: (2019)

Effect of 50% Hydro-Ethanolic Leaf Extracts of Ruellia Tuberosa L. and Dipteracanthus Patulus (Jacq.) on Lipid Profile in Alloxan Induced Diabetic Rats
por: Ananthakrishnan, Manikandan, et al.
Publicado: (2013)

Biosynthesis of Iron Oxide Nanoparticles Using Leaf Extract of Ruellia tuberosa: Mechanical and Dynamic Mechanical Behaviour Kevlar-Based Hybrid Epoxy Composites
por: Natrayan, L., et al.
Publicado: (2023)

Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
por: Zhao, Xu-Yun, et al.
Publicado: (2018)

Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats
por: Chang, Wen-Chang, et al.
Publicado: (2015)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

Gallic Acid Alleviates Hypertriglyceridemia and Fat Accumulation via Modulating Glycolysis and Lipolysis Pathways in Perirenal Adipose Tissues of Rats Fed a High-Fructose Diet
por: Huang, Da-Wei, et al.
Publicado: (2018)

Vescalagin from Pink Wax Apple (Syzygium samarangense (Blume) Merrill and Perry) Protects Pancreatic β-Cells against Methylglyoxal-Induced Inflammation in Rats
por: Chang, Wen-Chang, et al.
Publicado: (2021)

Modeling fructose-load-induced hepatic de-novo lipogenesis by model simplification
por: Allen, Richard J, et al.
Publicado: (2017)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
por: Hazlehurst, Jonathan M., et al.
Publicado: (2022)

Effects of α-Lipoic Acid on Phagocytosis of Oligomeric Beta-Amyloid(1–42) in BV-2 Mouse Microglial Cells
por: Ko, Chih-Yuan, et al.
Publicado: (2022)

Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
por: Podszun, Maren C., et al.
Publicado: (2020)

Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly
por: Flannery, Clare, et al.
Publicado: (2012)

Asclepias Tuberosa
por: Lockwood, T. T.
Publicado: (1848)

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
por: Paglialunga, Sabina, et al.
Publicado: (2016)

Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
por: Knebel, Birgit, et al.
Publicado: (2019)

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
por: Yao, Zhenyu, et al.
Publicado: (2023)

Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
por: Liou, Chian-Jiun, et al.
Publicado: (2020)

Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
por: Sanders, Francis W. B., et al.
Publicado: (2018)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019)

Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5rni17rs2jigug01k6gv7jj2gd